- Home
- BDTX vs ZVIA Comparison
BDTX vs ZVIA Comparison
Compare BDTX & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- ZVIA
- Stock Information
- Founded
- BDTX 2014
- ZVIA 2007
- Country
- BDTX United States
- ZVIA United States
- Employees
- BDTX N/A
- ZVIA N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- ZVIA Beverages (Production/Distribution)
- Sector
- BDTX Health Care
- ZVIA Consumer Staples
- Exchange
- BDTX Nasdaq
- ZVIA Nasdaq
- Market Cap
- BDTX 220.3M
- ZVIA 193.4M
- IPO Year
- BDTX 2020
- ZVIA 2021
- Fundamental
- Price
- BDTX $3.95
- ZVIA $2.38
- Analyst Decision
- BDTX Strong Buy
- ZVIA Buy
- Analyst Count
- BDTX 5
- ZVIA 5
- Target Price
- BDTX $10.40
- ZVIA $4.89
- AVG Volume (30 Days)
- BDTX 812.4K
- ZVIA 683.9K
- Earning Date
- BDTX 11-05-2025
- ZVIA 11-05-2025
- Dividend Yield
- BDTX N/A
- ZVIA N/A
- EPS Growth
- BDTX N/A
- ZVIA N/A
- EPS
- BDTX 0.25
- ZVIA N/A
- Revenue
- BDTX $70,000,000.00
- ZVIA $158,371,000.00
- Revenue This Year
- BDTX N/A
- ZVIA $6.44
- Revenue Next Year
- BDTX N/A
- ZVIA $6.68
- P/E Ratio
- BDTX $15.76
- ZVIA N/A
- Revenue Growth
- BDTX N/A
- ZVIA N/A
- 52 Week Low
- BDTX $1.20
- ZVIA $0.96
- 52 Week High
- BDTX $4.45
- ZVIA $4.99
- Technical
- Relative Strength Index (RSI)
- BDTX 55.41
- ZVIA 46.52
- Support Level
- BDTX $3.71
- ZVIA $2.29
- Resistance Level
- BDTX $4.08
- ZVIA $2.55
- Average True Range (ATR)
- BDTX 0.24
- ZVIA 0.11
- MACD
- BDTX -0.04
- ZVIA 0.01
- Stochastic Oscillator
- BDTX 35.90
- ZVIA 46.88
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.